Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advertising Endorsements May Be Limited Under Pending FTC Guidelines

This article was originally published in The Rose Sheet

Executive Summary

The Federal Trade Commission may issue new guidelines in 2007 limiting the use of endorsements and testimonials in ads, Venable LLP Partner Jeffrey Knowles stated during the Council of Better Business Bureaus' National Advertising Division annual conference in New York City Sept. 26

You may also be interested in...



Revision To FTC Testimonial Guidelines Would Muzzle Industry – Trade Groups

A proposed revision of Federal Trade Commission guidelines on advertising endorsements and testimonials would raise First Amendment concerns and could impose an "often impossible-to-meet requirement" on advertisers, according to the Electronic Retailing Association and the Council for Responsible Nutrition

Revision To FTC Testimonial Guidelines Would Muzzle Industry – Trade Groups

A proposed revision of Federal Trade Commission guidelines on advertising endorsements and testimonials would raise First Amendment concerns and could impose an "often impossible-to-meet requirement" on advertisers, according to the Electronic Retailing Association and the Council for Responsible Nutrition

Skin Care Formula’s Performance, Establishment Claims Challenged By ERSP

Direct response marketer Everderm will modify claims for its Everderm-CL skin care product following an inquiry by the National Advertising Review Council's Electronic Retailing Self-Regulation Program

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel